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Knowledge of asthma prevalence has been
increased greatly, especially in the last decade,
through the development of two international
collaborative studies: the International Study of
Asthma and Allergies in Childhood (ISAAC) for
children and adolescents; and the European
Community Respiratory Health Survey (ECRHS) for
adults. These studies were created as a response
to the need for reliable data, obtained by
reproducible methods and capable of providing
categorical evidence of the increased prevalence
of asthma and allergic diseases, which was
frequently reported in the early 1990s.
The ISAAC was designed to maximize the value of
epidemiological studies of asthma and allergic diseases,
establishing a standardized methodology in order to
facilitate the international collaboration. This study
had the following specific objectives: a) to describe
the prevalence and severity of asthma, rhinitis and
eczema among children living in various locations and
to draw comparisons among countries and among
locations within specific countries; b) obtain baseline
values in order to assess future tendencies in the
prevalence and severity of these diseases; c) provide a
structure for further etiologic studies into genetics,
lifestyle, medical care and environmental factors that
may affect these diseases(1). The ISAAC was born out
of two collaborative multinational studies of asthma
in children, making it possible to standardize the
written questionnaire (WQ) and video questionnaire
(VQ) research instruments, both of which had been
validated through pilot studies conducted in various
countries, confirming their applicability and
reproducibility(1). The WQ, composed of three modules
(asthma, rhinitis and atopic eczema), each comprising
up to eight easily-understood, self-administered
questions that do not depend on the presence of the
interviewer (significant source of error)(1).
Similarly to questionnaires used in other
epidemiological studies, the ISAAC WQ (asthma
module) consists of questions pertaining to asthma-
related symptoms, asthma severity and asthma
diagnosis. In order to avoid memory errors, the
majority of these questions refer to the preceding
year. The VQ deals only with asthma, containing
scenes of patients with asthma-related symptoms(1).
When conducting an epidemiological study, some
fundamental criteria must be met in order to guarantee
comparability among results obtained at the various
health care centers involved. In addition to the study
design (sample size calculation, age bracket, sample
selection, etc.), definition of the “cases” is essential.
Most studies evaluating asthma identify “asthma
sufferers” and categorize severity based on self-
reported asthma-related symptoms. On the standard
ISAAC WQ, the question “Have you ever had asthma?”
refers to physician-diagnosed asthma. In locations
where asthma is referred to by synonyms, this question
has very low sensitivity, despite presenting high
specificity. Various factors can interfere with responses
to this query by those who have been diagnosed with
asthma. Among such factors are understanding,
acceptance and recollection of the diagnosis. On the
standard ISAAC WQ, the question presenting the
highest rates of sensitivity and specificity is “Have you
experienced any wheezing within the last 12 months?”.
Some authors have correlated this question with
“current” or “active” asthma.
After the standard ISAAC WQ had been translated
into (Brazilian) Portuguese, it was validated (by criteria)
and applied in asthmatic adolescents who had been in
regular follow-up treatment at a specialized clinic for
over a year. Analysis of the responses given by these
patients showed that nearly all reported “wheezing
within the last 12 months”, and only half responded
positively to the “Have you ever had asthma?” question,
confirming the underdiagnosis caused by using the latter
question as a criterion for the selection of cases(2).
The initial phase of the ISAAC terminates with
the publication of the results obtained from the
various researchers who employed the protocol in
an independent fashion, some of whom made
94
modifications to the standard WQ. The most
significant change was the inclusion of a synonym
for asthma (“bronchitis”) in the question about the
medical diagnosis. The modified WQ identified similar
frequencies of affirmative responses to the questions
“Have you experienced wheezing within the last 12
months?” and “Have you ever had asthma or
bronchitis?”. However, since the standard WQ was
altered, direct comparison of these results with those
from other locales was not possible. In a previous
study, we added the question “Have you ever had
bronchitis?” to the standard WQ and determined that
the frequency of affirmative responses to this question
was identical to that of the question “Have you
experienced wheezing within the last 12 months?”,
reinforcing the assumption that, in our milieu, the
inclusion of synonyms for asthma is unnecessary.
Despite this evidence, there is still uncertainty
regarding the power of the question “Have you
experienced wheezing within the last 12 months?” in
identifying “cases”. In an attempt to lay this question
to rest, we determined the constructive validity of the
standard WQ, using patients with bronchial
hyperreactivity (proven by bronchoprovocation with
methacholine) as a reference for comparison. We found
that, in the identification of “cases”, this question
presented higher rates of sensitivity, specificity,
concordance, positive predictive values and negative
predictive values than did any other(3).
The first ISAAC phase, concluded in 1996, brought
together groups never before evaluated. In this phase,
119 facilities in 45 countries spanning every
populated continent (Europe, Asia, Africa, North
America, South America and Oceania) participated.
In 74 facilities (in 34 of those countries), 208,723
school children (aged 6 to 7) and 366,106 adolescents
(aged 13 to 14) were interviewed. The preliminary
analysis of the data shows great variation among the
results. The prevalence of “wheezing within the last
year” ranged from 1.6% to 27.2% in the 6 to 7 age
bracket and from 1.9 to 34.1% for those from 13 to
14 years of age. Physician-diagnosed asthma varied
from 1.3% to 30.8% among the school children and
from 1.8% to 30.2% among the adolescents. The
lowest values were reported in the Republic of
Georgia, in the Republic of Estonia and in the areas
of higher elevation in Australia(4).
In Brazil, seven health care centers (located in
the cities of Recife, Salvador, Uberlândia, Itabira, São
Paulo-Sul, Curitiba and Porto Alegre) participated in
the study. A total of 13,604 school children (6 to 7
age bracket) and 20,554 adolescents (13 to 14 age
bracket) were evaluated. The mean prevalence of
physician-diagnosed asthma was higher among boys
than among girls, (7.3%, 4.9%, 9.8% and 10.2% for
6-, 7-, 13- and 14-year-old boys, respectively)(5). The
prevalence of “wheezing within the last 12 months”
among school children ranged from 16.1% (in Itabira)
to 27.2% (in Recife and Porto Alegre), whereas,
among the adolescents, this ranged from 9.6% (in
Itabira) to 24.7% (in Recife) to 27.1% (in Salvador)(5).
These data confirm that the prevalence of physician-
diagnosed asthma is lower than that of “wheezing
within the last 12 months”, supporting the proposition
that use of the former criterion leads to
underdiagnosis. Another important point is regarding
asthma severity, which was unrelated to prevalence,
as evidenced by the fact that the more severe forms
of asthma were observed at a greater frequency in
Itabira(5). In comparison to he other participants in
phase I of the ISAAC, Brazil is in eighth place among
the countries with higher rates(4).
The results obtained in phase I confirm that the
ISAAC is a protocol of great value in epidemiological
studies of asthma in children and adolescents. It has
made it possible for researchers other than those
involved in the project to use the same method and
instrument to obtain data in other locations, as was
done in the study conducted by Boechat et al.,
published in this issue of the Jornal Brasileiro de
Pneumologia (Brazilian Journal of Pulmonology)(7). The
data collected by the authors showed prevalence rates
that were higher than those obtained in Brazil by the
end of phase I of the ISAAC. Even when compared to
the combined data from children evaluated at all other
Brazilian health care centers using the standard WQ
(23,457 school children and 40,111 adolescents), the
mean prevalence of “wheezing in the last 12 months”
in the Boechat et al. study was higher among school
children (27.7% for 6 year olds and 25.7% for 7 year
olds) and lower among adolescents (21.4% for 13
year olds and 19.9% for 14 year olds).
In conclusion, the ISAAC was a landmark global
study of asthma and allowed us to determine that
the prevalence of asthma in Brazil is high, reaching
levels seen in more developed countries. Employing
physician diagnosis of asthma as a criterion for
identifying “cases” resulted in underdiagnosis and
prevented us from determining the true dimensions
of asthma in our country. The results of ISAAC
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Pursuing MEDLINE
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phase I I I ,  recent ly completed and as yet
unpublished, will be important for assessing
whether in Brazil, as in other countries, the
prevalence of asthma in Brazil is on the rise.
DIRCEU SOLÉ
Professor Emeritus in the Allergy, Clinical Immunology and
Rheumatology Sector of the Departament of Pediatrics at the
Universidade Federal de São Paulo-Escola Paulista de Medicina
REFERÊNCIAS
1. Asher MI, Keil U, Anderson HR, Beasley R, Crane J,
Martinez F et al. International study of asthma and
allergies in childhood (ISAAC): rationale and methods.
Eur Respir J 1995, 8: 483-91.
2 . Solé D, Vanna AT, Yamada E, Rizzo MC, Naspitz
CK. International study of asthma and allergies in
c h i l d hood  ( I SAAC )  w r i t t e n  qu e s t i o nna i r e :
v a l i d a t i o n  o f  t h e  a s t hma  c omponen t  among
Brazilian children. J Invest Allergol Clin Immunol
1998; 8: 376-82.
3 . Came lo-Nunes  IC .  Va l i dação  cons t ru t i va  do
quest ionár io escr i to do “ internac ional  s tudy of
a s thma and  a l l e rg i e s  i n  ch i l dhood”  ( I SAAC )  e
caracterização da asma em adolescentes.  [Tese],
Universidade Federal de São Paulo - Escola Paulista
de Medicina, São Paulo, 2002, 174p.
4. ISAAC Steering Committee. Worldwide variation in
prevalence of symptoms of asthma, allergic
rhinoconjunctivitis, and atopic eczema: ISAAC. The
International Study of Asthma and Allergies in Childhood
(ISAAC) Steering Committee. Lancet 1998; 351: 1225-32.
5 . Solé D, Yamada E, Vana AT, Werneck G, Freitas LS,
Sologuren MJ et al - International study of asthma
and allergies in childhood (ISAAC): Prevalence of
a s t hma  and  a s t hma- r e l a t ed  s ymp toms  among
Braz i l ian schoolch i ld ren .  J  Invest  A l le rgo l  C l in
Immunol 2001; 11: 123-8.
6 . Camelo-Nunes IC, Wandalsen GF, Sole D - Asthma
in Brazil ian school-age children: a public health
matter? J Pediatr (Rio J). 2003; 79: 472-3.
7 . Boechat JL, Rios JL, Sant’Anna CC,  França AT.
Prevalência e gravidade de sintomas relacionados à
asma em escolares e adolescentes no município de
Duque de Caxias, Rio de Janeiro. J Bras Pneumol
2005; 2: 111-7.
The MEDLINE system, sponsored by the United
States National Library of Medicine (NLM) is the most
important online database of scientific journals in
the area of biomedicine. The system evolved out of
the union of the Index Medicus, last published in
2004, and other, lesser, databases. Access to MEDLINE
is available for free on the Internet, and the database
is consulted daily by thousands of researchers and
professionals in the areas of health and biological
sciences. In these fields, there are approximately
14,000 journals in current publication worldwide. Of
those, approximately 4800 are listed in MEDLINE(1).
The members of the Sociedade Brasileira de
Pneumologia e Tisiologia (SBPT, Brazilian Society of
Pulmonology and Phthisiology) have long hoped that
the Jornal Brasileiro de Pneumologia (JBP, Brazilian
Journal of Pulmonology) would be selected for
indexing in MEDLINE. We are frequently asked when
this will occur. To answer to this question, it is
necessary to explain the process by which journals
are evaluated by the NLM.
The decision as to whether or not a journal
will be indexed in MEDLINE is ultimately made
by the director of the NLM, based on advice given
by the Literature Selection Technical Review
Committee (LSTRC). The final decision should be
made in accordance with the general policies
adopted by the LSTRC, which are in turn dictated
by the Board of Regents of the Library (2). The
LSTRC is composed of fifteen members, each
affiliated with the National Institutes of Health,
and meets three times per year. At every meeting,
approximately 140 indexing requests, from
journals the world over, are evaluated(1,2). The
committee analyzes the last four issues of each
petitioning journal. On average, only 25 to 30%
of the journals evaluated are selected for indexing.
The LSTRC evaluates a journal in various
aspects(2):
a. Scope and coverage: The journal should
contain articles predominantly on core biomedical
subjects.
